Dysgerminomas comprise approximately 25% of all ovarian malignancies and mostly affect young adolescent women. Primary comprehensive surgery and adjuvant chemotherapy consisting of bleomycin, etoposide, and cisplatin (BEP) are the current recommended treatment options, the latter reserved for advanced stages (FIGO IIIV). We report two patients aged 20 and 26 years who presented with an initial FIGO stage IA, but inadequately assessed. Both were subsequently diagnosed with recurrent malignant dysgerminoma and para-aortic lymph node metastasis. Neither had received comprehensive staging at initial surgery nor adjuvant radio or chemotherapy. Both needed extensive surgery and multiagent chemotherapy for survival and belong to the small percentage of FIGO IA dysgerminoma patients showing a relapse. Comprehensive initial surgery including systematic para-aortic lymphadenectomy and adjuvant chemotherapy at tertiary referral centers is needed to minimize the treatment burden. © 2009 Informa UK Ltd.
CITATION STYLE
Kasenda, B., Harter, P., Hirsch, T., Ast, A., Buhrmann, C., Glaser, F., & Du Bois, A. (2009). Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary. Acta Obstetricia et Gynecologica Scandinavica, 88(11), 1288–1290. https://doi.org/10.3109/00016340903242461
Mendeley helps you to discover research relevant for your work.